The estimated Net Worth of Scott D Thomas is at least 159 千$ dollars as of 18 May 2023. Scott Thomas owns over 1,468 units of Seer stock worth over 153,807$ and over the last 3 years Scott sold SEER stock worth over 5,226$.
Sign up
Scott Thomas SEER stock SEC Form 4 insiders trading
Scott has made over 1 trades of the Seer stock since 2023, according to the Form 4 filled with the SEC. Most recently Scott sold 1,468 units of SEER stock worth 5,226$ on 18 May 2023.
The largest trade Scott's ever made was selling 1,468 units of Seer stock on 18 May 2023 worth over 5,226$. On average, Scott trades about 489 units every 0 days since 2022. As of 18 May 2023 Scott still owns at least 95,532 units of Seer stock.
You can see the complete history of Scott Thomas stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Scott Thomas's mailing address?
Scott's mailing address filed with the SEC is C/O SEER, INC., 3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY, CA, 94065.
Insiders trading at Seer
Over the last 7 years, insiders at Seer have traded over 150,878,393$ worth of Seer stock and bought 1,798,420 units worth 33,507,980$ . The most active insiders traders include Omid Farokhzad、Terrance Mcguire、Growth Fund Limited Partner.... On average, Seer executives and independent directors trade stock every 60 days with the average trade being worth of 227,813$. The most recent stock trade was executed by Dipchand Nishar on 14 June 2024, trading 12,109 units of SEER stock currently worth 21,554$.
What does Seer do?
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
What does Seer's logo look like?
Complete history of Scott Thomas stock trades at Seer
Seer executives and stock owners
Seer executives and other stock owners filed with the SEC include:
-
Dr. Omid C. Farokhzad M.D., Ph.D.,
Founder, CEO & Chair of the Board of Directors -
Dr. Omid C. Farokhzad Ph.D., M.D.,
CEO & Chair of the Board of Directors -
Omead Ostadan,
Part Time Pres, COO & Director -
David R. Horn,
Exec. VP & Chief Financial Officer -
Martin Goldberg Ph.D.,
Sr. VP of Devel. -
Elona Kogan Esq., J.D.,
Gen. Counsel & Sec. -
Marissa Dixon,
VP & Chief People Officer -
Jennifer Maggio,
VP & Corp. Controller -
Dr. Serafim Batzoglou,
VP & Chief of Computation -
Shashanka Muppaneni,
VP of Corp. Devel. -
Karen Possemato,
VP of Corp. Marketing & Communications -
Elona Kogan J.D., Esq.,
Gen. Counsel & Sec. -
Dr. Philip Ma Ph.D.,
Founder & Strategic Advisor -
Joe Laws,
Chief Technology Officer and Co-Founder -
David Hallal,
-
Rachel E. Haurwitz,
-
Dipchand Nishar,
-
Mostafa Ronaghi,
Director -
David B Singer,
Director -
Public Equities, L.P.Invus ...,
-
Omead Ostadan,
President & COO -
David R. Horn,
PRESIDENT & CFO -
Growth Fund Limited Partner...,
-
Capital Ventures, Llc Maver...,
-
Cathy Friedman,
Director -
Terrance Mcguire,
-
Capital Ventures, Llc Maver...,
-
Robert Langer,
-
Scott D Thomas,
Chief Commercial Officer -
Public Equities, L.P.Artal ...,
-
Meeta Gulyani,
-
Omid Farokhzad,
CEO AND CHAIR -
Elona Kogan,
CHIEF LEGAL OFFICER -
Nicolas H Phd Roelofs,